Monkeypox Testing Market 2030: PCR Technology Leading the Charge
Global Monkeypox Testing Market Overview The global monkeypox testing market was valued at USD 1.79 million in 2021 and is projected to reach USD 2.63 million by 2030, growing at a CAGR of 4.35% from 2022 to 2030. A significant surge in monkeypox cases globally and the declaration of a "Public Health Emergency" led the market to spike to USD 184.11 million in 2022. The rapid expansion of the market is primarily driven by the increasing global incidence of monkeypox and the complexity in determining the core cause behind the disease’s transmission. These uncertainties, coupled with strong government actions to contain the virus and prevent future pandemics, are contributing to the market’s overall growth. With rising case numbers and the launch of innovative products that offer faster diagnostic results, the monkeypox testing market is set to grow at a healthy pace. Since treatment options remain under investigation, expanding testing capabilities has become critical. For...